Vascular endothelial growth factor (VEGF)-A is overexpressed in most malignant and
premalignant breast lesions. VEGF-A can be visualized noninvasively with PET imaging and …

Molecular imaging of breast cancer can potentially be used for breast cancer screening,
staging, restaging, response evaluation and guiding therapies. Techniques for molecular …

Vascular endothelial growth factor (VEGF), released by tumor cells, is an important growth
factor in tumor angiogenesis. The humanized monoclonal antibody bevacizumab blocks …

Purpose Noninvasive positron emission tomography (PET) imaging of vascular endothelial
growth factor receptor 2 (VEGFR-2) expression could be a valuable tool for evaluation of …

The pivotal role of vascular endothelial growth factor (VEGF) in cancer is underscored by the
approval of bevacizumab (Bev, a humanized anti-VEGF monoclonal antibody) for first line …

Purpose Tumour angiogenesis is an independent and strong prognostic factor in early
breast carcinoma. We performed this study to investigate the ability of 18 F-FDG to detect …

In recent years, there has been a growing interest in molecular imaging markers of tumor-
induced angiogenesis. Several radiolabeled RGD (arginine, glycine, aspartate) peptides …

Objective Using integrated 18F-fluorodeoxyglucose positron emission
tomography/computed tomography fusion imaging (18F-FDG PET/CT), the clinical …

Objectives To determine whether a correlation exists between maximum standardized
uptake value (SUV max) on 18 F-fluorodeoxyglucose positron emission tomography (FDG …

For solid tumors and metastatic lesions, tumor vascularity is a critical factor in assessing
response to therapy. Here we report the first example, to our knowledge, of 64Cu-labeled …